Who owns ArriVent BioPharma, Inc.?
Institutional ownership of AVBP from SEC Form 13F filings across 107 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
107
13F holders
$735.5M
value, 2026 filers
45.9%
of shares outstanding (21.4M sh)
22
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30· % of fund = share of the manager's own book · % of co. = share of AVBP's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | MONTANOVA CAPITAL, LLC | 4.5M | $156.9M | 2.9% | 9.7% | +2.6% |
| 2 | BlackRock, Inc. | 3.3M | $112.9M | 0.0% | 7% | +28.5% |
| 3 | FMR LLC | 2.8M | $96.5M | 0.0% | 6% | -7.9% |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 1.8M | $61.7M | 0.0% | 3.8% | -42.0% |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 972,626 | $33.8M | 0.0% | 2.1% | +21.0% |
| 6 | D. E. Shaw & Co., Inc. | 872,011 | $30.3M | 0.0% | 1.9% | +136.4% |
| 7 | GOLDMAN SACHS GROUP INC | 853,723 | $29.7M | 0.0% | 1.8% | 0.0% |
| 8 | Point72 Asset Management, L.P. | 566,796 | $19.7M | 0.0% | 1.2% | -24.2% |
| 9 | MILLENNIUM MANAGEMENT LLC | 438,664 | $15.2M | 0.0% | 0.9% | +3.0% |
| 10 | UBS Group AG | 438,594 | $15.2M | 0.0% | 0.9% | -9.8% |
| 11 | Balyasny Asset Management L.P. | 395,447 | $13.7M | 0.0% | 0.8% | -7.2% |
| 12 | AMERIPRISE FINANCIAL INC | 381,589 | $13.3M | 0.0% | 0.8% | +112.0% |
| 13 | VANGUARD PORTFOLIO MANAGEMENT LLC | 335,320 | $11.6M | 0.0% | 0.7% | +32.1% |
| 14 | NORTHERN TRUST CORP | 332,753 | $11.6M | 0.0% | 0.7% | +23.8% |
| 15 | Sixth Street Partners Management Company, L.P.NEW | 294,224 | $10.2M | 1.8% | 0.6% | new |
| 16 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 294,224 | $10.2M | 0.0% | 0.6% | +13.7% |
| 17 | VANGUARD FIDUCIARY TRUST CO | 259,290 | $9.0M | 0.0% | 0.6% | +19.4% |
| 18 | MORGAN STANLEY | 189,910 | $6.6M | 0.0% | 0.4% | +47.7% |
| 19 | BANK OF AMERICA CORP /DE/ | 174,866 | $6.1M | 0.0% | 0.4% | +118.0% |
| 20 | CITADEL ADVISORS LLC | 156,742 | $5.4M | 0.0% | 0.3% | -5.7% |
| 21 | NOMURA HOLDINGS INC | 154,617 | $5.4M | 0.0% | 0.3% | -36.1% |
| 22 | Woodline Partners LP | 147,639 | $5.1M | 0.0% | 0.3% | -50.0% |
| 23 | HRT FINANCIAL LP | 121,224 | $4,211 | 0.0% | 0.3% | +157.6% |
| 24 | Nuveen, LLC | 107,851 | $3.7M | 0.0% | 0.2% | +89.7% |
| 25 | Bank of New York Mellon Corp | 103,931 | $3.6M | 0.0% | 0.2% | +37.8% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.